Global Netupitant-Palonosetron FDC Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Netupitant-Palonosetron FDC Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
The netupitant-palonosetron FDC is an oral therapy that targets two critical pathways associated with acute and delayed CINV by blockage of P/NK1 receptors. Netupitant in the central nervous system inhibits the binding of endogenous tachykinin neuropeptide substance, which prevents chemotherapy-induced nausea and vomiting (CINV).
Netupitant-Palonosetron FDC report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Netupitant-Palonosetron FDC market is projected to reach US$ 546270 million in 2034, increasing from US$ 296760 million in 2022, with the CAGR of 8.6% during the period of 2024 to 2034. Demand from Retail Pharmacy and Online Pharmacy are the major drivers for the industry.
Presently, patient pool segment has witnessed large-scale adoption of netupitant-palonosetron FDC drugs due to rise in number of patient undergoing chemotherapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Netupitant-Palonosetron FDC market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Eisai Pharmaceutical
Helsinn
Heron Therapeutics
Tesaro
Acacia Pharma
Segment by Type
Flakes
Capsules
Other
Retail Pharmacy
Online Pharmacy
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Netupitant-Palonosetron FDC market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Netupitant-Palonosetron FDC, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Netupitant-Palonosetron FDC industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Netupitant-Palonosetron FDC in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Netupitant-Palonosetron FDC introduction, etc. Netupitant-Palonosetron FDC Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Netupitant-Palonosetron FDC market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Netupitant-Palonosetron FDC report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Netupitant-Palonosetron FDC market is projected to reach US$ 546270 million in 2034, increasing from US$ 296760 million in 2022, with the CAGR of 8.6% during the period of 2024 to 2034. Demand from Retail Pharmacy and Online Pharmacy are the major drivers for the industry.
Presently, patient pool segment has witnessed large-scale adoption of netupitant-palonosetron FDC drugs due to rise in number of patient undergoing chemotherapy.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Netupitant-Palonosetron FDC market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Eisai Pharmaceutical
Helsinn
Heron Therapeutics
Tesaro
Acacia Pharma
Segment by Type
Flakes
Capsules
Other
Segment by Application
Retail Pharmacy
Online Pharmacy
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Netupitant-Palonosetron FDC market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Netupitant-Palonosetron FDC, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Netupitant-Palonosetron FDC industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Netupitant-Palonosetron FDC in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Netupitant-Palonosetron FDC introduction, etc. Netupitant-Palonosetron FDC Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Netupitant-Palonosetron FDC market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices